May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China.

Autor: Chen X; Department of Cardiovascular Medicine, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Zhang LP; Department of Internal Medicine, Hospital of Shanxi Datong University, Shanxi, China., Wang XL; Department of Cardiology, People's Hospital of Hongsibao District, Ningxia, China., Zhang NR; Department of Cardiology, The First Affiliated Hospital of Bengbu Medical University, Anhui, China., Yu J; Department of Cardiology, Lanzhou University Second Hospital, Gansu, China., Xu LY; Department of Cardiology, The Forth People's Hospital of Datong City, Shanxi, China., Li TS; Department of Cardiology, Luoyang Dongfang People's Hospital, Henan, China., Luan H; Department of Cardiology, People's Hospital of Ningxia Hui Autonomous Region, Ningxia, China., Zhang J; Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Henan, China., Hu YM; Department of Cardiology, Cangzhou Central Hospital, Hebei, China., Liu D; Department of Cardiology, The First People's Hospital of Zunyi, Guizhou, China., Zheng QD; Department of Internal Medicine, Yuhuan Second Peoples' Hospital, Zhejiang, China., Li Y; Department of Cardiovascular Medicine, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Wang JG; Department of Cardiovascular Medicine, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Jazyk: angličtina
Zdroj: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2024 Oct 22. Date of Electronic Publication: 2024 Oct 22.
DOI: 10.1111/jch.14919
Abstrakt: We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID-19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1-min interval in the sitting position, using a validated automated BP monitor (Omron HEM-7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n  =  29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n =  1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p < 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p < 0.001) and moderate or heavy alcohol drinking (n = 3871, +0.4/+0.7 mm Hg, p < 0.05), and overweight (+1.8/+1.4 mm Hg, p < 0.001) and obesity (+2.3/+1.5 mm Hg, p < 0.001). In conclusion, our study provided unique blood pressure data during the COVID-19 period, and suggested that hypertension management might have been even more challenging when the medical professionals had to shift their focus on other urgencies.
(© 2024 The Author(s). The Journal of Clinical Hypertension published by Wiley Periodicals LLC.)
Databáze: MEDLINE